These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 18772037)

  • 1. Dynamics of the dopaminergic system as a key component to the understanding of depression.
    Yadid G; Friedman A
    Prog Brain Res; 2008; 172():265-86. PubMed ID: 18772037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decoding of dopaminergic mesolimbic activity and depressive behavior.
    Friedman A; Deri I; Friedman Y; Dremencov E; Goutkin S; Kravchinsky E; Mintz M; Levi D; Overstreet DH; Yadid G
    J Mol Neurosci; 2007; 32(1):72-9. PubMed ID: 17873290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The serotonin-dopamine interaction is critical for fast-onset action of antidepressant treatment: in vivo studies in an animal model of depression.
    Dremencov E; Gispan-Herman I; Rosenstein M; Mendelman A; Overstreet DH; Zohar J; Yadid G
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):141-7. PubMed ID: 14687868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin-dopamine interactions: implications for the design of novel therapeutic agents for psychiatric disorders.
    Wood MD; Wren PB
    Prog Brain Res; 2008; 172():213-30. PubMed ID: 18772035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A new concept of antidepressant drugs action: clinical and preclinical data].
    Płaźnik A; Kostowski W
    Psychiatr Pol; 1994; 28(1):39-50. PubMed ID: 7910691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine, depression and antidepressants.
    Dailly E; Chenu F; Renard CE; Bourin M
    Fundam Clin Pharmacol; 2004 Dec; 18(6):601-7. PubMed ID: 15548230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic deficit and mood disorders.
    Pania L; Gessab GL
    Int Clin Psychopharmacol; 2002 Dec; 17 Suppl 4():S1-7; discussion S7. PubMed ID: 12685916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mesolimbic dopamine reward circuit in depression.
    Nestler EJ; Carlezon WA
    Biol Psychiatry; 2006 Jun; 59(12):1151-9. PubMed ID: 16566899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic-based pharmacotherapies for depression.
    Papakostas GI
    Eur Neuropsychopharmacol; 2006 Aug; 16(6):391-402. PubMed ID: 16413172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic agents and stimulants as antidepressant augmentation strategies.
    Nierenberg AA; Dougherty D; Rosenbaum JF
    J Clin Psychiatry; 1998; 59 Suppl 5():60-3; discussion 64. PubMed ID: 9635549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARα modulation of mesolimbic dopamine transmission rescues depression-related behaviors.
    Scheggi S; Melis M; De Felice M; Aroni S; Muntoni AL; Pelliccia T; Gambarana C; De Montis MG; Pistis M
    Neuropharmacology; 2016 Nov; 110(Pt A):251-259. PubMed ID: 27457507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence.
    Müller N
    Curr Opin Investig Drugs; 2010 Jan; 11(1):31-42. PubMed ID: 20047157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VTA dopamine neuron bursting is altered in an animal model of depression and corrected by desipramine.
    Friedman A; Friedman Y; Dremencov E; Yadid G
    J Mol Neurosci; 2008 Mar; 34(3):201-9. PubMed ID: 18197479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the role of metabotropic glutamate receptors in the mechanisms of action of antidepressants.
    Pałucha A; Pilc A
    Pol J Pharmacol; 2002; 54(6):581-6. PubMed ID: 12866712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphodiesterase 10A inhibition modulates the sensitivity of the mesolimbic dopaminergic system to D-amphetamine: involvement of the D1-regulated feedback control of midbrain dopamine neurons.
    Sotty F; Montezinho LP; Steiniger-Brach B; Nielsen J
    J Neurochem; 2009 May; 109(3):766-75. PubMed ID: 19236563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D2-like receptors and the antidepressant response.
    Gershon AA; Vishne T; Grunhaus L
    Biol Psychiatry; 2007 Jan; 61(2):145-53. PubMed ID: 16934770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of dopamine transmission by 5HT2C and 5HT3 receptors: a role in the antidepressant response.
    Dremencov E; Weizmann Y; Kinor N; Gispan-Herman I; Yadid G
    Curr Drug Targets; 2006 Feb; 7(2):165-75. PubMed ID: 16475958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of postnatal isolation rearing and antidepressant treatment on the density of serotonergic and noradrenergic axons and depressive behavior in rats.
    Kuramochi M; Nakamura S
    Neuroscience; 2009 Sep; 163(1):448-55. PubMed ID: 19524023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interest of using genetically manipulated mice as models of depression to evaluate antidepressant drugs activity: a review.
    Gardier AM; Guiard BP; Guilloux JP; Repérant C; Coudoré F; David DJ
    Fundam Clin Pharmacol; 2009 Feb; 23(1):23-42. PubMed ID: 19267769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interrelations between neuromediators implicated in depression and antidepressive drugs].
    Tassin JP
    Encephale; 1994 Dec; 20 Spec No 4():623-8. PubMed ID: 7895628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.